[CH2:1]([C:3]1[NH:4][CH:5]=[C:6]([CH3:8])[N:7]=1)[CH3:2].[C:9]([C:13]1[CH:20]=[CH:19][C:16]([CH2:17]Br)=[CH:15][CH:14]=1)([O:11][CH3:12])=[O:10].N1C=CN=C1.CC([O-])=O.[Na+].C=O>CC(O)=O>[CH2:1]([C:3]1[N:4]([CH2:17][C:16]2[CH:19]=[CH:20][C:13]([C:9]([O:11][CH3:12])=[O:10])=[CH:14][CH:15]=2)[CH:5]=[C:6]([CH3:8])[N:7]=1)[CH3:2]Methyl 4-[[2-ethyl-4-methyl-1H-imidazol-1-yl]methyl]benzoate compound was prepared from 2-ethyl-4-methyl-imidazole and (4-carbmethoxy)benzylbromide in an analogous fashion as described in Example 11. A solution of the above imidazole (2.17 g, 8.14 mmol), NaOAc 1.17 g), 37% HCHO (10 mL), and AcOH (1.2 mL) was heated under reflux for 22 hours. The solution was evaporated under vacuo, and the residue was stirred with 10 mL of 20% NaOH solution for 2 hours. It was diluted with water and the solution was extracted with CH2Cl2. The extract was washed with water, dried, and evaporated to an oil. It was chromatographed (CH2Cl2 /MeOH, 2-5%) to give 1.0 g of the desired hydroxymethyl compound as a foam. MS (CI) 288 (m).